Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100

Por Agelink, M, Andrich, J, Postert, T, Wurzinger, U, Zeit, T, Klotz, P, Przuntek, H
Publicado em 2001

Autonomic nervous system function in Huntington's disease

Por Andrich, J, Schmitz, T, Saft, C, Postert, T, Kraus, P, Epplen, J, Przuntek, H, Agelink, M
Publicado em 2002

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease

Por Saft, C, Andrich, J, Brune, N, Gencik, M, Kraus, P, Przuntek, H, Epplen, J
Publicado em 2004

Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography

Por Postert, T., Lack, B, Kuhn, W, Jergas, M, Andrich, J, Braun, B, Przuntek, H, Sprengelmeyer, R, Agelink, M, Buttner, T.
Publicado em 1999

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study

Por Kassubek, J, Juengling, F, Kioschies, T, Henkel, K, Karitzky, J, Kramer, B, Ecker, D, Andrich, J, Saft, C, Kraus, P, Aschoff, A, Ludolph, A, Landwehrmeyer, G
Publicado em 2004

Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype

Por Bauer, P, Laccone, F, Rolfs, A, Wullner, U, Bosch, S, Peters, H, Liebscher, S, Scheible, M, Epplen, J, Weber, B, Holinski-Feder, E, Weirich-Schwaiger, H, Morris-Rosendahl, D, Andrich, J, Riess, O
Publicado em 2004